PSYCHO-ONCOLOGY

metrics 2024

Navigating the Emotional Landscape of Cancer

Introduction

PSYCHO-ONCOLOGY is a leading international journal published by Wiley, focusing on the interdisciplinary fields of psychology and oncology. Established in 1992 and continuing its impactful contributions to academic discourse through 2024, the journal occupies a prestigious position with a Q1 ranking in Experimental and Cognitive Psychology and notable placements in both Oncology and Psychiatry and Mental Health categories. With an impressive Scopus ranking that places it in the 86th and 76th percentiles within its respective fields, PSYCHO-ONCOLOGY facilitates the exploration of psychological dimensions of cancer and its treatment, emphasizing evidence-based research that greatly informs clinical practices. Researchers, professionals, and students benefit from its comprehensive scope, which encompasses mental health implications linked to cancer diagnosis, treatment, and survivorship. Although it operates on a subscription model, the journal remains a vital resource for advancing knowledge and promoting psychosocial well-being in oncology, making it an essential read for those dedicated to improving patient outcomes.

Metrics 2024

SCIMAGO Journal Rank1.14
Journal Impact Factor3.30
Journal Impact Factor (5 years)4.40
H-Index158
Journal IF Without Self3.30
Eigen Factor0.01
Normal Eigen Factor2.96
Influence1.31
Immediacy Index0.50
Cited Half Life7.70
Citing Half Life7.20
JCI0.80
Total Documents4417
WOS Total Citations14321
SCIMAGO Total Citations43451
SCIMAGO SELF Citations3823
Scopus Journal Rank1.14
Cites / Document (2 Years)3.23
Cites / Document (3 Years)3.62
Cites / Document (4 Years)3.94

Metrics History

Rank 2024

Scopus

Experimental and Cognitive Psychology in Psychology
Rank #23/165
Percentile 86.06
Quartile Q1
Psychiatry and Mental Health in Medicine
Rank #136/567
Percentile 76.01
Quartile Q1
Oncology in Medicine
Rank #115/404
Percentile 71.53
Quartile Q2

IF (Web Of Science)

ONCOLOGY
Rank 118/322
Percentile 63.50
Quartile Q2
PSYCHOLOGY
Rank 16/92
Percentile 83.20
Quartile Q1
PSYCHOLOGY, MULTIDISCIPLINARY
Rank 36/218
Percentile 83.70
Quartile Q1
SOCIAL SCIENCES, BIOMEDICAL
Rank 6/46
Percentile 88.00
Quartile Q1

JCI (Web Of Science)

ONCOLOGY
Rank 116/322
Percentile 63.98
Quartile Q2
PSYCHOLOGY
Rank 35/92
Percentile 61.96
Quartile Q2
PSYCHOLOGY, MULTIDISCIPLINARY
Rank 84/218
Percentile 61.47
Quartile Q2
SOCIAL SCIENCES, BIOMEDICAL
Rank 22/46
Percentile 52.17
Quartile Q2

Quartile History

Similar Journals

Psycho-Oncologie

Transforming Cancer Care with Psychological Perspectives.
Publisher: TECH SCIENCE PRESSISSN: 1778-3798Frequency: 4 issues/year

Psycho-Oncologie is a specialized academic journal dedicated to the intersection of psychology and oncology, published by TECH SCIENCE PRESS. With an ISSN of 1778-3798 and E-ISSN of 1778-381X, this journal serves as an important platform for researchers and practitioners seeking to understand the psychological impact of cancer on patients and their families. Established in 2007 and converging with its findings through 2024, Psycho-Oncologie aims to disseminate high-quality research that enhances mental health and promotes effective treatment strategies within the oncological landscape. Although currently holding a Q4 ranking in disciplines such as Clinical Psychology and Oncology, the journal is committed to maintaining a high standard of research integrity and scientific rigor to foster future advancements. Although it operates under a non-open access model, the journal strives to make its valuable insights available to a broader audience. For those in the fields of psychology, oncology, and health care, Psycho-Oncologie is an essential resource for staying abreast of critical developments and contributing to interdisciplinary approaches in cancer treatment.

GERONTOLOGIST

Connecting Scholars to Enhance Aging Research
Publisher: OXFORD UNIV PRESS INCISSN: 0016-9013Frequency: 6 issues/year

The GERONTOLOGIST, published by Oxford University Press Inc, is a premier journal in the field of geriatrics and gerontology, with a distinguished history since its inception in 1961. This esteemed journal stands out with its impressive Q1 rankings in prominent categories, including Geriatrics and Gerontology, reflecting its vital role in disseminating innovative research and advancing knowledge within these critical disciplines. With an impact factor that ranks it among the top journals in both Nursing Gerontology and Medicine, the GERONTOLOGIST serves as a key resource for researchers, professionals, and students dedicated to enhancing the health and well-being of older adults. Although it operates under a traditional access model, the journal remains committed to publishing cutting-edge studies that address the complexities of aging and inform evidence-based practices. By fostering a rich dialogue among scholars and practitioners, the GERONTOLOGIST is instrumental in shaping the future of gerontological research and policy.

International Journal of Cancer Management

Advancing cancer care through innovative research.
Publisher: BRIEFLANDISSN: 2538-4422Frequency: 12 issues/year

The International Journal of Cancer Management is a distinguished publication dedicated to advancing knowledge and research in the fields of cancer management, oncology, pharmacology, and radiology. Published by BRIEFLAND in the Netherlands, this journal serves as a vital resource for researchers, healthcare professionals, and students interested in the latest developments in cancer care and treatment strategies. With an ISSN of 2538-4422 and an E-ISSN of 2538-497X, the journal features a range of peer-reviewed articles that cover diverse aspects of cancer management, reflecting its commitment to high-quality, impactful research. The journal ranks in the Q4 category for Cancer Research and Oncology and Q3 for both Pharmacology and Surgery in 2023, signifying its growing influence in the scientific community. Through its open access format, the International Journal of Cancer Management ensures that critical research findings are accessible to all, promoting collaboration and innovation in the battle against cancer. Researchers looking to share their findings or learn more about current trends will find this journal an invaluable addition to their professional toolkit.

PSYCHOLOGY & HEALTH

Advancing Insights into Health Psychology.
Publisher: TAYLOR & FRANCIS LTDISSN: 0887-0446Frequency: 12 issues/year

Psychology & Health is a leading academic journal published by Taylor & Francis Ltd, dedicated to advancing the understanding of psychological influences on health and well-being. Since its inception in 1987, the journal has been pivotal in disseminating high-quality research, with a current ISSN of 0887-0446 and E-ISSN of 1476-8321. Recognized for its contributions to the field, it holds esteemed rankings, being classified in the Q2 quartile in Applied Psychology and Q1 quartile in Public Health (2023). With Scopus rankings placing it in the 87th percentile for Public Health and 80th in Applied Psychology, *Psychology & Health* provides researchers, professionals, and students with invaluable insights into the intersection of psychological research and health outcomes. The journal offers a rich platform for exploring contemporary issues and methodologies, encouraging submissions that advance the field and promote interdisciplinary dialogue. Although it is not an open-access journal, articles are available through institutional subscriptions, ensuring robust accessibility for the academic community.

Current Oncology

Innovative Insights for Oncology Professionals
Publisher: MDPIISSN: 1198-0052Frequency: 12 issues/year

Current Oncology is a prominent open-access journal dedicated to the field of oncology, published by MDPI in Switzerland. With an ISSN of 1198-0052 and E-ISSN 1718-7729, this esteemed journal has been providing valuable insights since its inception in 1998 and continues to publish cutting-edge research through 2024. Recognized for its contribution to the medical community, Current Oncology holds a 2023 Q2 category rank in Oncology and is positioned at the 41st percentile among its peers in Scopus rankings. As a hub for innovation and discussion in cancer research, it offers a plethora of articles that span various aspects of oncology, making it an essential resource for researchers, professionals, and students alike. Since becoming fully open-access in 2006, it provides expanded accessibility to groundbreaking studies and findings, fostering collaboration and knowledge exchange across the global research community. With its central location in Basel, Switzerland, Current Oncology plays a pivotal role in advancing oncology's frontiers.

Asian Oncology Nursing

Elevating Oncology Nursing Standards Across Asia
Publisher: KOREAN ONCOLOGY NURSING SOCISSN: 2287-2434Frequency: 3 issues/year

Asian Oncology Nursing is a pivotal journal dedicated to advancing the field of oncology nursing across the Asian continent and beyond. Published by the esteemed Korean Oncology Nursing Society, this journal serves as a platform for researchers, clinicians, and educators to disseminate groundbreaking findings and innovative practices in cancer care and nursing. With an ISSN of 2287-2434 and E-ISSN 2093-7776, it is committed to enhancing the knowledge and skills of oncology nursing professionals, thereby improving patient outcomes. Although currently not operating as an open-access platform, the journal emphasizes the significance of bridging the research gap in oncology nursing, fostering collaboration among professionals in the field. Given the increasing importance of culturally competent care in oncology, Asian Oncology Nursing positions itself as an essential resource for those who strive to elevate standards of care and educate future generations of oncology nurses.

Journal of Adolescent and Young Adult Oncology

Transforming Cancer Care for Adolescents and Young Adults
Publisher: MARY ANN LIEBERT, INCISSN: 2156-5333Frequency: 6 issues/year

The Journal of Adolescent and Young Adult Oncology, published by MARY ANN LIEBERT, INC, is a premier peer-reviewed journal dedicated to enhancing the understanding and treatment of cancers in adolescents and young adults. With an ISSN of 2156-5333 and an E-ISSN of 2156-535X, this journal specializes in providing vital insights into the unique challenges faced by younger cancer patients, promoting research and clinical best practices in this underrepresented population. The journal features a commendable ranking in the Q2 quartile for Oncology and Q1 quartile for Pediatrics, Perinatology, and Child Health—highlighting its impact and relevance in both fields. Its Scopus rankings also reflect a strong standing; positioned at Rank #107/330 in Pediatrics and Rank #225/404 in Oncology. While the journal operates under a subscription-based model, it aims to disseminate crucial research findings and innovative treatments through its engaging content that serves as an invaluable resource for researchers, clinicians, and students alike. Since its inception in 2014, the journal has been at the forefront of addressing the pressing issues pertinent to young cancer patients, making it a vital outlet for groundbreaking studies and clinical advancements within this critical area of healthcare.

CA-A CANCER JOURNAL FOR CLINICIANS

Delivering Essential Knowledge for Oncology and Hematology Experts
Publisher: WILEYISSN: 0007-9235Frequency: 6 issues/year

CA: A Cancer Journal for Clinicians is a prestigious academic journal published by Wiley, serving as a leading source of evidence-based information for those in the fields of oncology and hematology. With an impressive impact factor and ranked in the top quartile (Q1) for both specialties, this journal aims to bridge the gap between the latest research findings and clinical practice. Established in 1950, it boasts a long-standing history of delivering essential insights, guidelines, and innovative strategies to healthcare professionals worldwide, making significant contributions to the understanding and treatment of cancer. Although it does not offer open access, its published content is crucial for researchers, clinicians, and students dedicated to advancing cancer care. The journal's commitment to excellence is reflected in its elite rankings, holding the #1 position in both the Medicine – Oncology and Medicine – Hematology categories according to Scopus, positioning it in the 99th percentile of scholarly impact.

Cancer Control

Transforming insights into impactful cancer solutions.
Publisher: SAGE PUBLICATIONS INCISSN: 1073-2748Frequency: 1 issue/year

Cancer Control is a prominent open-access journal published by SAGE Publications Inc, dedicated to advancing the field of oncology, hematology, and general medicine since its inception in 1995. With a focus on disseminating high-quality research, the journal contributes significantly to the knowledge base surrounding cancer prevention, treatment, and survivorship, making it a vital resource for researchers, healthcare professionals, and students alike. The journal currently holds a commendable position in the academic landscape, ranking in the Q2 category for both Hematology and Oncology, highlighting its impact and scholarly relevance. Available in an open-access format since 2018, Cancer Control ensures that critical findings are accessible to a broad audience, promoting collaboration and innovation in cancer-related research. Whether you're interested in the latest clinical trials, epidemiological studies, or public health initiatives, this journal serves as a key platform for sharing significant developments in cancer care and control.

Breast Cancer

Advancing knowledge in breast cancer research.
Publisher: SPRINGER JAPAN KKISSN: 1340-6868Frequency: 6 issues/year

Breast Cancer is a prestigious peer-reviewed journal published by SPRINGER JAPAN KK, specializing in the multifaceted domains of oncology and medical pharmacology. With an impressive impact factor and recognized within the Q1 category in multiple areas, including Medicine (miscellaneous), Radiology, and Nuclear Medicine and Imaging, this journal serves as a fundamental resource for cutting-edge research and clinical advancements in breast cancer treatment and care. Its indexed presence in renowned databases like Scopus further affirms its significance, ranking 56th in Radiology and 60th in Pharmacology. The journal aims to bridge the gap between clinical practice and scientific research by publishing original articles, reviews, and case studies that enhance understanding and improve patient outcomes. With converged content available from 1994 to 2024, the journal is dedicated to fostering innovative research while engaging a global audience of researchers, clinicians, and students passionate about tackling breast cancer challenges.